These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37405578)

  • 1. Add-On Effect of 0.01% Atropine in Orthokeratology Wearers for Myopia Control in Children: A 2-Year Retrospective Study.
    Du L; Chen J; Ding L; Wang J; Yang J; Xie H; Xu X; He X; Zhu M
    Ophthalmol Ther; 2023 Oct; 12(5):2557-2568. PubMed ID: 37405578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-year results of 0.01% atropine with orthokeratology (AOK) study: a randomised clinical trial.
    Tan Q; Ng AL; Choy BN; Cheng GP; Woo VC; Cho P
    Ophthalmic Physiol Opt; 2020 Sep; 40(5):557-566. PubMed ID: 32776533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher order aberrations and axial elongation in combined 0.01% atropine with orthokeratology for myopia control.
    Vincent SJ; Tan Q; Ng ALK; Cheng GPM; Woo VCP; Cho P
    Ophthalmic Physiol Opt; 2020 Nov; 40(6):728-737. PubMed ID: 32888318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive effects of orthokeratology and atropine 0.01% ophthalmic solution in slowing axial elongation in children with myopia: first year results.
    Kinoshita N; Konno Y; Hamada N; Kanda Y; Shimmura-Tomita M; Kakehashi A
    Jpn J Ophthalmol; 2018 Sep; 62(5):544-553. PubMed ID: 29974278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Atropine with Orthokeratology for Myopia Control: Study Design and Preliminary Results.
    Tan Q; Ng AL; Cheng GP; Woo VC; Cho P
    Curr Eye Res; 2019 Jun; 44(6):671-678. PubMed ID: 30632410
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined 0.01% atropine with orthokeratology in childhood myopia control (AOK) study: A 2-year randomized clinical trial.
    Tan Q; Ng AL; Cheng GP; Woo VC; Cho P
    Cont Lens Anterior Eye; 2023 Feb; 46(1):101723. PubMed ID: 35654683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Add-on effect of using 0.05% atropine in fast progressors of orthokeratology: A preliminary retrospective study.
    Wen L; Liu H; Xu Q; Pan W; Lin Z; Xiao Z; Yang Z; Lan W; Chen Z
    Cont Lens Anterior Eye; 2024 Jul; ():102282. PubMed ID: 39069400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overnight orthokeratology is comparable with atropine in controlling myopia.
    Lin HJ; Wan L; Tsai FJ; Tsai YY; Chen LA; Tsai AL; Huang YC
    BMC Ophthalmol; 2014 Mar; 14():40. PubMed ID: 24685184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of 0.01% atropine alone or combined with orthokeratology for children with myopia: A meta-analysis.
    Wang Z; Wang P; Jiang B; Meng Y; Qie S; Yan Z
    PLoS One; 2023; 18(7):e0282286. PubMed ID: 37494360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 0.02% atropine eye drops, peripheral myopia defocus design spectacle lenses, and orthokeratology for myopia control.
    Wang M; Ji N; Yu SA; Liang LL; Ma JX; Fu AC
    Clin Exp Optom; 2024 Nov; 107(8):813-819. PubMed ID: 38043135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low concentration atropine combined with orthokeratology in the treatment of axial elongation in children with myopia: A meta-analysis.
    Yang N; Bai J; Liu L
    Eur J Ophthalmol; 2022 Jan; 32(1):221-228. PubMed ID: 33678055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions to slow progression of myopia in children.
    Walline JJ; Lindsley KB; Vedula SS; Cotter SA; Mutti DO; Ng SM; Twelker JD
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004916. PubMed ID: 31930781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of 0.01% atropine in retarding the progression of myopia in children.
    Zhao Q; Hao Q
    Int Ophthalmol; 2021 Mar; 41(3):1011-1017. PubMed ID: 33205372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in subfoveal choroidal thickness in myopic children with 0.01% atropine, orthokeratology, or their combination.
    Hao Q; Zhao Q
    Int Ophthalmol; 2021 Sep; 41(9):2963-2971. PubMed ID: 33954859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical observation and analysis on the effect of orthokeratology in myopic anisometropic children].
    Lyu YY; Wu JJ; Guo W; Peng L; Wang YX; Wu M; Cao K; Jie Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Apr; 55(4):471-477. PubMed ID: 33858058
    [No Abstract]   [Full Text] [Related]  

  • 16. Orthokeratology Lenses Versus Administration of 0.01% Atropine Eye Drops for Axial Length Elongation in Children With Myopic Anisometropia.
    Ji N; Niu Y; Qin J; Fu AC; Cui C
    Eye Contact Lens; 2022 Jan; 48(1):45-50. PubMed ID: 34924543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Clinical Efficacies of 0.01% Atropine and Orthokeratology in Controlling the Progression of Myopia in Children.
    Zhao Q; Hao Q
    Ophthalmic Epidemiol; 2021 Oct; 28(5):376-382. PubMed ID: 33472507
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of Administration of 0.02% Atropine and Orthokeratology for Myopia Control.
    Lyu Y; Ji N; Fu AC; Wang WQ; Wei L; Qin J; Zhao BX
    Eye Contact Lens; 2021 Feb; 47(2):81-85. PubMed ID: 32443010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-year add-on effect of using low concentration atropine in poor responders of orthokeratology in myopic children.
    Chen Z; Zhou J; Xue F; Qu X; Zhou X
    Br J Ophthalmol; 2022 Aug; 106(8):1069-1072. PubMed ID: 33707188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pattern of Axial Length Growth in Children Myopic Anisometropes with Orthokeratology Treatment.
    Long W; Li Z; Hu Y; Cui D; Zhai Z; Yang X
    Curr Eye Res; 2020 Jul; 45(7):834-838. PubMed ID: 31821058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.